These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37259073)

  • 41. Hepatitis C virus risk among young people who inject drugs.
    Mateu-Gelabert P; Sabounchi NS; Guarino H; Ciervo C; Joseph K; Eckhardt BJ; Fong C; Kapadia SN; Huang TTK
    Front Public Health; 2022; 10():835836. PubMed ID: 35968435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
    Iversen J; Wand H; McManus H; Dore GJ; Maher L
    Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. On the way to Hepatitis C elimination in the Republic of Georgia-Barriers and facilitators for people who inject drugs for engaging in the treatment program: A formative qualitative study.
    Chikovani I; Ompad DC; Uchaneishvili M; Sulaberidze L; Sikharulidze K; Hagan H; Van Devanter NL
    PLoS One; 2019; 14(4):e0216123. PubMed ID: 31034530
    [TBL] [Abstract][Full Text] [Related]  

  • 44. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
    Goodyear T; Ti L; Carrieri P; Small W; Knight R
    Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Integrated supervised consumption services and hepatitis C testing and treatment among people who inject drugs in Toronto, Canada: A cross-sectional analysis.
    Greenwald ZR; Bouck Z; McLean E; Mason K; Lettner B; Broad J; Dodd Z; Nassau T; Scheim AI; Werb D
    J Viral Hepat; 2023 Feb; 30(2):160-171. PubMed ID: 36461705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of a tool to assess effectiveness of peer-recruitment for hepatitis C testing and linkage to care among people who inject drugs.
    Falade-Nwulia O; Momoh O; Felsher M; Nwulia E; Tofighi B; Ward K; McCormick S; Sulkowski M; Latkin C
    Drug Alcohol Depend; 2022 Jan; 230():109177. PubMed ID: 34808487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries.
    Maticic M; Pirnat Z; Leicht A; Zimmermann R; Windelinck T; Jauffret-Roustide M; Duffell E; Tammi T; Schatz E
    Harm Reduct J; 2020 Nov; 17(1):89. PubMed ID: 33213481
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.
    Lazarus JV; Sperle I; Maticic M; Wiessing L
    BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S16. PubMed ID: 25252742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.
    Artenie AA; Roy É; Zang G; Jutras-Aswad D; Bamvita JM; Puzhko S; Daniel M; Bruneau J
    Int J Drug Policy; 2015 Oct; 26(10):970-5. PubMed ID: 26005038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
    Blackburn NA; Patel RC; Zibbell JE
    Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C Testing, Status and Treatment among Marginalized People Who Use Drugs in an Inner City Setting: An Observational Cohort Study.
    Boucher LM; Bayoumi AM; Mark AE; Cooper C; Martin A; Marshall Z; Boyd R; Oickle P; Diliso N; Pineau D; Renaud B; LeBlanc S; Tyndall M; Lee OM; Kendall CE
    Subst Use Misuse; 2019; 54(1):18-30. PubMed ID: 29932800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.
    Karimi SE; Bayani A; Higgs P; Bayat AH; Hemmat M; Ahounbar E; Armoon B; Fakhri Y
    Subst Abuse Treat Prev Policy; 2020 Aug; 15(1):64. PubMed ID: 32831107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Home-based hepatitis C self-testing in people who inject drugs and men who have sex with men in Georgia: a protocol for a randomised controlled trial.
    Shilton S; Stvilia K; Japaridze M; Tsereteli N; Usharidze D; Phevadze S; Jghenti M; Mozalevskis A; Markby J; Luhmann N; Johnson C; Nabeta P; Ongarello S; Reipold EI; Gamkrelidze A
    BMJ Open; 2022 Sep; 12(9):e056243. PubMed ID: 36691209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risky injection practices and HCV awareness in Chiang Mai Province, Thailand: a respondent-driven sampling study of people who inject drugs.
    Prouté M; Le Coeur S; Tiv MH; Dub T; Jongpaijitsakul P; Ratnamhin A; Angkurawaranon C; Aramrattana A; Lallemant M
    BMC Public Health; 2020 Sep; 20(1):1450. PubMed ID: 32972359
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.
    Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ
    Int J Drug Policy; 2018 Feb; 52():115-122. PubMed ID: 29414462
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada.
    Saeed S; Strumpf EC; Moodie EE; Young J; Nitulescu R; Cox J; Wong A; Walmsely S; Cooper C; Vachon ML; Martel-Laferriere V; Hull M; Conway B; Klein MB;
    J Int AIDS Soc; 2017 Nov; 20(3):. PubMed ID: 29116684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk behaviours of homeless people who inject drugs during an outbreak of hepatitis C, Northern Ireland, 2016-2017.
    Maisa A; Semple S; Griffiths A; Ngui SL; Verlander NQ; McCaughey C; Doherty L; Jessop L;
    J Viral Hepat; 2019 Dec; 26(12):1377-1387. PubMed ID: 31328838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interventions to prevent HIV and Hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness.
    MacArthur GJ; van Velzen E; Palmateer N; Kimber J; Pharris A; Hope V; Taylor A; Roy K; Aspinall E; Goldberg D; Rhodes T; Hedrich D; Salminen M; Hickman M; Hutchinson SJ
    Int J Drug Policy; 2014 Jan; 25(1):34-52. PubMed ID: 23973009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.